In Vivo Disease Models

Accelerate your research by maximizing the insights gained through in vivo work. By conducting cell-based assays to inform your studies and completing histology and flow cytometry in-house, we can help you get the most out of your in vivo pharmacology studies.

Our expertise in in vivo model development allows us to develop customized solutions and expand our offerings beyond traditional models.

Get Started

Oncology & Immuno-Oncology Models

Develop cancer treatments and immunotherapeutics with models covering various cancer types with syngeneic, CDX, PDX, and custom models.

Ophthalmology Models

Leverage our aged macular degeneration models and our custom models to develop novel ophthalmology treatments.

NASH Models

Study metabolic and fatty liver disease with chronic and acute nonalcoholic steatohepatitis (NASH) models.

Other In Vivo Models

We have experience working with a variety of in vivo pharmacology models, genetic models, surgical models, and models based on drug mechanisms of action. If we don’t have what you’re looking for, we’d love to develop a custom in vivo model for you.

Geriatric Models

Analyze the impact of treatments over a long period of time by leveraging our expertise in handling aged and senescent models.

Learn more about running in vivo model preclinical studies at Ichor’s Vivarium.

Learn More About Running In Vivo Model Preclinical Studies at Ichor’s Vivarium.

We offer preclinical in vivo disease models for a variety of research applications using mice, rats, and rabbits to meet client needs. Our facilities prioritized animal welfare by promoting species-specific behaviors with enrichment activities.

Ready to advance your preclinical research with in vivo models?

Gain the in vivo pharmacology information you need to move your therapeutic forward.

Frequently Asked Questions

We’re different from other CROs, which tends to lead to a lot of questions. Here are the answers to some common ones related to our in vivo disease models.

What in vivo models do you work with? Can you build a custom model?

What kind of drug modalities can you handle?

What type of routes of administrations can you handle?

What animal species do you work with?

How soon can you start a study once a contract is in place?

Featured Resources

Publications

Recombinant Manganese Peroxidase Reduces A2E Burden in Age-Related and Stargardt's Macular Degeneration Models

Coevolution of the Ess1-CTD axis in polar fungi suggests a role for phase separation in cold tolerance

Case Studies

Case Study: Development of a SPR Chip

Case Study: Establishing Novel FRET Protocols with Novel Tagging Systems